GlassScriptPhysician profile
Ian Kendall Chapman
NPI 1922705557
$2,646.68
in general payments reported to CMS, 2019-2025
31 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $902 · 2024: $1,325 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,646.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $352.05 | 2023-2025 | Airsupra, Farxiga, Fasenra |
| Lundbeck LLC | $254.94 | 2024-2025 | Vyepti, Rexulti, Brintellix |
| Abbvie INC. | $216.85 | 2023-2024 | |
| Pfizer INC. | $176.96 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $158.64 | 2023-2025 | Rexulti, Abilify Maintena |
| Takeda Pharmaceuticals U.S.A., INC. | $155.84 | 2023-2024 | Glassia, Trintellix, Aralast |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $149.15 | 2024 | Caplyta |
| Amgen INC. | $128.46 | 2023-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $115.81 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Kowa Pharmaceuticals America, INC. | $98.34 | 2023-2024 | Seglentis, Livalo, Zoryve |
| Exact Sciences Corporation | $87.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $84.42 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Aimmune Therapeutics, INC. | $78.75 | 2024-2025 | Zenpep |
| Janssen Pharmaceuticals, INC | $74.47 | 2023-2024 | Xarelto, Spravato |
| Sumitomo Pharma America, INC. | $68.06 | 2023-2024 | Gemtesa |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $64.81 | 2023-2024 | Nexletol |
| Medtronic, INC. | $61.39 | 2023-2025 | Minimed 780g, Minimed 770g |
| Idorsia Pharmaceuticals US INC | $45.80 | 2023-2024 | Quviviq |
| Axsome Therapeutics, INC. | $42.58 | 2025 | Auvelity |
| Antares Pharma, INC. | $38.78 | 2024 | Xyosted |
| Hologic Sales and Service, LLC | $23.29 | 2024 | Aptima, Thinprep 2000 Processor |
| Abbott Laboratories | $20.78 | 2024 | Freestyle Libre 3 |
| Vifor Pharma, INC. | $20.67 | 2025 | Zemaira |
| Recordati_rare_diseases_inc. | $18.60 | 2024 | Isturisa, Signifor Lar |
| Shield Therapeutics INC | $18.37 | 2023 | Accrufer |
| Boston Scientific Corporation | $18.01 | 2024 | |
| Halozyme INC | $15.22 | 2023 | |
| Cranial Technologies, INC | $15.02 | 2024 | Doc Band |
| Bayer Healthcare Pharmaceuticals INC. | $14.85 | 2023 | |
| Scilex Pharmaceuticals INC. | $14.85 | 2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $13.84 | 2023 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.